Cargando…
P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis
TP53 also known as p53 is a tumor suppressor gene mutated in a variety of cancers. P53 is involved in cell cycle, apoptosis and DNA repair mechanisms and is thus tightly controlled by many regulators. Recently, strategies to treat cancer have focused on the development of MDM2 antagonists to induce...
Autores principales: | Mahfoudhi, Emna, Lordier, Larissa, Marty, Caroline, Pan, Jiajia, Roy, Anita, Roy, Lydia, Rameau, Philippe, Abbes, Salem, Debili, Najet, Raslova, Hana, Chang, Yunhua, Debussche, Laurent, Vainchenker, William, Plo, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077990/ https://www.ncbi.nlm.nih.gov/pubmed/26959882 http://dx.doi.org/10.18632/oncotarget.7881 |
Ejemplares similares
-
Role of Rho-GTPases in megakaryopoiesis
por: Vainchenker, William, et al.
Publicado: (2021) -
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis
por: Plo, Isabelle, et al.
Publicado: (2017) -
p19(INK4d) Controls Hematopoietic Stem Cells in a Cell-Autonomous Manner during Genotoxic Stress and through the Microenvironment during Aging
por: Hilpert, Morgane, et al.
Publicado: (2014) -
Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms
por: Ali, A, et al.
Publicado: (2013) -
Critical role of the HDAC6–cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect
por: Messaoudi, Kahia, et al.
Publicado: (2017)